X-group (possible homology)

4019 alpha-helical domain in beta-lactamase/transpeptidase-like proteins

Ligands and drugs

4,174
Member domains
2,925
with ligand contacts (≤ 4 Å)
70.1% of members
2,621
with DrugDomain annotations
62.8% of members
1,381
with a DrugBank compound
33.1% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

220
Proteins with classified ligands
13
Superclasses bound (of 23)
8.4
Superclasses per 20 proteins
broader than 65% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Organic acids and derivatives14333.64.26×q < 0.0001
Benzenoids4115.92.58×q < 0.0001
Organoheterocyclic compounds7033.42.10×q < 0.0001
Organic nitrogen compounds126.91.73×q = 0.12
Homogeneous non-metal compounds6346.71.35×q = 0.02
Organic oxygen compounds3443.20.79×q = 0.18
Homogeneous metal compounds40106.50.38×q < 0.0001
Lipids and lipid-like molecules824.20.33×q = 3.9e-4
Nucleosides, nucleotides, and analogues360.00.05×q < 0.0001
Organic salts10.24.43×not tested
Organosulfur compounds64.51.34×not tested
Phenylpropanoids and polyketides54.51.11×not tested
Mixed metal/non-metal compounds14.60.22×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB08375CEF(2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid44
DB03530CAZAcylated ceftazidime26
DB03834TBE(3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine22
DB09157CO2Carbon dioxide21
DB04035CB4Ceftazidime BATSI19
DB00142GLUGlutamic acid18
DB021451BOButyl alcohol13
DB04133CEDDegraded Cephaloridine13
DB00145GLYGlycine12
DB00355AZRAztreonam12
DB08551SM23-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid12
DB121074D6Vaborbactam11
DB00513ACAAminocaproic acid10
DB03658AXL(2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid10
DB04360BZBBenzo[B]Thiophene-2-Boronic Acid10
DB00130GLNL-Glutamine9
DB093240RNSulbactam9
DB1523263JTelaglenastat8
DB00766J01Clavulanic acid7
DB01896APBM-Aminophenylboronic Acid7

Most frequently bound compounds

PDB ligandNameDomains in contact
CLCHLORIDE ION214
NXL(2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide123
NAmetalSODIUM ION71
IM2(5R)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-[(2-{[(E)-iminomethyl]amino}ethyl)sulfanyl]-4,5-dihydro-1H-pyrrole-2-carboxylic acid45
ZNmetalZINC ION41
CDmetalCADMIUM ION40
PNMOPEN FORM - PENICILLIN G39
MER(4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid36
9F2Ceftriaxone34
TSLTRANS-ENAMINE INTERMEDIATE OF SULBACTAM34
CEFCEFOTAXIME, C3' cleaved, open, bound form33
CAmetalCALCIUM ION28
CAZACYLATED CEFTAZIDIME27
ID1Imipenem27
IODIODIDE ION27
Y33(5R)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid27
KmetalPOTASSIUM ION25
CO2CARBON DIOXIDE24
BAmetalBARIUM ION23
TBETAZOBACTAM INTERMEDIATE22